Edwards Lifesciences Master Plan Modification; File No. 00945396-PMPC
Summary
SCH Number
2025070226
Public Agency
City of Irvine
Document Title
Edwards Lifesciences Master Plan Modification; File No. 00945396-PMPC
Document Type
NOE - Notice of Exemption
Received
Posted
7/3/2025
Document Description
The project consists of a master plan modification with a transfer of
development rights for the Edwards Lifesciences campus to modify and
expand the campus buildout by adding an existing approximately 96,000-
square-foot building into the master plan, converting land uses within
existing buildings, and allowing a 2,340-square-foot addition to an existing
warehouse building.
Contact Information
Name
Eric Martin
Agency Name
City of Irvine
Job Title
Senior Planner
Contact Types
Lead/Public Agency
Phone
Name
Jeff Gingold
Agency Name
Edwards Lifesciences
Job Title
Applicant
Contact Types
Project Applicant
Address
Phone
Email
Location
Cities
Irvine
Counties
Orange
Regions
Southern California
Zip
92614
Other Location Info
The project is located at 1 Edwards Way, Irvine, CA 92614, in the County
of Orange.
Notice of Exemption
Exempt Status
Categorical Exemption
Type, Section or Code
Section 15301, Class 1 for Existing Facilities
Reasons for Exemption
This project is categorically exempt under Section 15301, Class 1,
Existing Facilities, because the project involves negligible or no
expansion of the existing use and will involve minor additions to an
existing warehouse building and interior alterations within existing
buildings. Furthermore, the project is in an area that can be
adequately served by existing utilities and public services, and the
project is not located in an environmentally sensitive area.
County Clerk
Orange
Attachments
Notice of Exemption
Disclaimer: The Governor’s Office of Land Use and Climate Innovation (LCI) accepts no responsibility for the content or accessibility of these documents. To obtain an attachment in a different format, please contact the lead agency at the contact information listed above. For more information, please visit LCI’s Accessibility Site.